Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Pablo Revilla-Martí, Jose A. Linares-Vicente, Ana Martínez Labuena, Octavio Jiménez Melo, Paula Morlanes Gracia, Daniel Meseguer González, Antonela Lukic, Borja Simó Sánchez & Jose R. Ruiz Arroyo. (2022) Efficacy and safety of abciximab versus tirofiban in addition to ticagrelor in STEMI patients undergoing primary percutaneous intervention. Platelets 33:2, pages 265-272.
Read now
Read now
Glenn F King. (2011) Venoms as a platform for human drugs: translating toxins into therapeutics. Expert Opinion on Biological Therapy 11:11, pages 1469-1484.
Read now
Read now
Articles from other publishers (7)
Hue N. T. Tran, Poanna Tran, Jennifer R. Deuis, Akello J. Agwa, Alan H. Zhang, Irina Vetter & Christina I. Schroeder. (2019)
Enzymatic Ligation of a Pore Blocker Toxin and a Gating Modifier Toxin: Creating Double-Knotted Peptides with Improved Sodium Channel Na
V
1.7 Inhibition
. Bioconjugate Chemistry 31:1, pages 64-73.
Crossref
Crossref
Hamed Memariani, Mojtaba Memariani, Hamideh Moravvej & Mohammad Shahidi-Dadras. (2019) Melittin: a venom-derived peptide with promising anti-viral properties. European Journal of Clinical Microbiology & Infectious Diseases 39:1, pages 5-17.
Crossref
Crossref
Isadora Sousa de Oliveira, Rafaella Varzoni Manzini, Isabela Gobbo Ferreira, Iara Aimê Cardoso, Karla de Castro Figueiredo Bordon, Ana Rita Thomazela Machado, Lusânia Maria Greggi Antunes, José Cesar Rosa & Eliane Candiani Arantes. (2018) Cell migration inhibition activity of a non-RGD disintegrin from Crotalus durissus collilineatus venom. Journal of Venomous Animals and Toxins including Tropical Diseases 24:1.
Crossref
Crossref
V.O. Zambelli, K.F.M. Pasqualoto, G. Picolo, A.M. Chudzinski-Tavassi & Y. Cury. (2016) Harnessing the knowledge of animal toxins to generate drugs. Pharmacological Research 112, pages 30-36.
Crossref
Crossref
Joachim Fauler. (2009) Clinical pharmacology of antithrombotic drugs in coronary artery disease. Therapeutic Advances in Cardiovascular Disease 3:6, pages 465-478.
Crossref
Crossref
Barry S. Coller & Sanford J. Shattil. (2008) The GPIIb/IIIa (integrin αIIbβ3) odyssey: a technology-driven saga of a receptor with twists, turns, and even a bend. Blood 112:8, pages 3011-3025.
Crossref
Crossref
Michał Ciborowski, Marian Tomasiak, Tomasz Rusak, Katarzyna Winnicka & Sławomir Dobrzycki. (2008) The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets. Blood Coagulation & Fibrinolysis 19:6, pages 557-567.
Crossref
Crossref